Sanochemia: New partnership for treating melanoma with anticancer peptides

Sanochemia is collaborating with the University of Graz and Newfield Therapeutics Corporation, Charlotte, USA to develop new anticancer peptides. Sanochemia plans to become the exclusive manufacturing partner of these drugs and to market them in the EMEA region.

Sorry, this entry is only available in German!

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)